Development of an EORTC Quality of Life Module for Renal Cell Cancer Patients: Phase I by L. Wintner, E. Beisland, C. Beisland, M. Van Hemelrijck, B. Holzner

Get full text

Transcriptomic characterization of renal cell carcinoma patients with progressive disease despite low initial risk of progression by S. Nakken, Ø. Eikrem, H-P. Marti, C. Beisland, A. Scherer, V. Beisvag, A. Flatberg, P. Strauss

Get full text

Serum levels of the IL-33 decoy receptor soluble ST2; a possible prognostic marker in clear-cell renal cell carcinoma by H.H. Aarstad, G. Gudbrandsdottir, K.M. Hjelle, T.H.A. Tvedt, Ø. Bruserud, L. Bostad, H.J. Aarstad, C. Beisland

Get full text

Does the detection of human papillomavirus (HPV) DNA in penile carcinoma hold prognostic information regarding patient survival? by C.A. Moen, T.K. Thorkelsen, L. Bostad, O.E. Rio, A. Honore, A.A. Chaudhry, P. Juliebø-Jones, C. Beisland

Get full text

Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castrati... by L.C.V. Thomsen, A. Honoré, B. Almås, L.A.R. Reisæter, K. Førde, E.K. Kristoffersen, S.H. Kaada, G.K. Melve, S.I. Helle, G. Kvalheim, W. Azeem, J.R. Olsen, O.J. Halvorsen, L.A. Akslen, D. Bahn, K. Pantel, S. Riethdorf, H. Ragde, B.T. Gjertsen, A.M. Øyan, K.H. Kalland, C. Beisland

Get full text